Restart Life Sciences Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HEAL.CN research report →
Companywww.restartlife.co
Restart Life Sciences Corp. , through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome.
- CEO
- Steve Loutskou
- IPO
- 2006
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $3.47M
- P/E
- -2.32
- P/S
- 0.00
- P/B
- 2.50
- EV/EBITDA
- -1.58
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -379.02%
- ROIC
- -87.79%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,390,538 · -718.72%
- EPS
- $-0.04 · -500.00%
- Op Income
- $-1,345,316
- FCF YoY
- -899.29%
Performance & Tape
- 52W High
- $0.14
- 52W Low
- $0.06
- 50D MA
- $0.10
- 200D MA
- $0.10
- Beta
- -0.87
- Avg Volume
- 73.52K
Get TickerSpark's AI analysis on HEAL.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HEAL.CN Coverage
We haven't published any research on HEAL.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HEAL.CN Report →